arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ESTABLISHMENT LABS HOLDINGS INC.

ESTA
$67.67 ▼ -2.57 (-3.66%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
39 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

ESTABLISHMENT LABS HOLDINGS INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.0B
Dividend Yield —
Revenue Growth 31.7% ↘
Op. Margin -6.4% ↗
ROIC -1.5% ↗
FCF / Share $-0.67 ↘
Trailing P/E —
Price / Book 93.3x
FCF Yield —
Debt / Equity 12.11
info Valuation on last close. End-of-day price, Sep 23, 2026.

39-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$67.54M
↑ +31.7% —
Net Income Profit after all expenses
$-13.38M
↑ +35.4% —
Operating Margin Operating profit as % of sales
-6.4%
↑ +41.6% 11th
FCF / Share Free cash flow per share
$-0.67
↓ -226.8% —
Long-Term Debt Long-term obligations
$261.70M
↑ +5.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
9
Returns ↓
1
Financial Health ↑
22
Cash Quality ↑
70

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 39 quarters